Recent Finacing
Recent Raise
Cimeio Therapeutics develops gene‑edited cell‑shielding platforms that insert antibody‑evading protein variants to protect transplanted hematopoietic and adoptive cell therapies from antibodies, T‑cell engagers, ADCs and CAR‑T.
